ロード中...

Checkpoint inhibitors in hematological malignancies

Inhibitory molecules such as PD-1, CTLA-4, LAG-3, or TIM-3 play a role to keep a balance in immune function. However, many cancers exploit such molecules to escape immune surveillance. Accumulating data support that their functions are dysregulated in lymphoid neoplasms, including plasma cell myelom...

詳細記述

保存先:
書誌詳細
出版年:J Hematol Oncol
主要な著者: Ok, Chi Young, Young, Ken H.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422942/
https://ncbi.nlm.nih.gov/pubmed/28482851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0474-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!